A novel long non-coding RNA-based prognostic signature for renal cell carcinoma patients with stage IV and histological grade G4

References

• Linehan WM, Ricketts CJ. The cancer genome atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019;16(9):539–552.
   PubMed Web of Science ®Google Scholar
• Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387(10021):894–906.
   PubMed Web of Science ®Google Scholar
• Pu Y, Dong Z, Xia Y, et al. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG. Biomed Pharmacother. 2019;118:109382.
   PubMed Web of Science ®Google Scholar
• Bex A, Powles T, Haanen J, et al. Sunitinib alone or after nephrectomy in renal cancer. N Engl J Med. 2018;379:1877–1878.
   PubMed Web of Science ®Google Scholar
• Chi Y, Wang D, Wang J, et al. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019;8:1-44.
   Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS, et al. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–159.
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21.
   PubMed Web of Science ®Google Scholar
• Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. 2010;7(5):582–585.
   PubMed Web of Science ®Google Scholar
• Qu L, Wang ZL, Chen Q, et al. Prognostic value of a long non-coding RNA signature in localized clear cell renal cell carcinoma. Eur Urol. 2018;74:756–763.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang X, Piao C, et al. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma. Biomed Pharmacother. 2019;118:109079.
   PubMed Web of Science ®Google Scholar
• Li S, Yang J, Shen Y, et al. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database. BMC Public Health. 2019;19(1):1592.
   PubMed Web of Science ®Google Scholar
• Tomczak K, Czerwińska P, Wiznerowicz M, et al. The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19:A68–77.
   PubMedGoogle Scholar
• Heagerty PJ, Lumley T, Pepe MS, et al. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–344.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• von Mering C, Huynen M, Jaeggi D, et al. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31:258–261.
   PubMed Web of Science ®Google Scholar
• Doncheva NT, Morris JH. Cytoscape stringApp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18:623–632.
   Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.
   Google Scholar
• Siegel RL, Miller KD, Sauer AG, et al. Cancer statistics, 2020. Ca A Cancer J Clinicians. 2020;70:7–30.
   PubMed Web of Science ®Google Scholar
• Hua KC, Hu YC. Establishment of predictive model for patients with kidney cancer bone metastasis: a study based on SEER database. Transl Androl Urol. 2020;9:523–543.
   PubMed Web of Science ®Google Scholar
• Ma B, Li Y, Ren Y, et al. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Cancer Med. 2020;9:335–349.
   Google Scholar
• Liu H, Ye T, Yang X, et al. A panel of four-lncRNA signature as a potential biomarker for predicting survival in clear cell renal cell carcinoma. J Cancer. 2020;11(14):4274–4283.
   PubMed Web of Science ®Google Scholar
• Zuo S, Wang L, Wen Y, et al. Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma. J Cell Biochem. 2018;120:7375-7385.
   Web of Science ®Google Scholar
• Liu Y, Gou X, Wei Z, et al. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma. Aging (Albany NY). 2020;12:15359–15373.
   PubMedGoogle Scholar
• Chen B, Wang C, Zhang J, et al. New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma. Cancer Cell Int. 2018;18(1):157.
   PubMedGoogle Scholar
• Wang J, Yu Z, Wang J, et al. LncRNA NUTM2A-AS1 positively modulates TET1 and HIF-1A to enhance gastric cancer tumorigenesis and drug resistance by sponging miR-376a. Cancer Med. 2020;9:9499–9510.
   Google Scholar
• Acha-Sagredo A, Uko B, Pantazi P, et al. Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis. Br J Cancer. 2020;122(7):1050–1058.
   PubMed Web of Science ®Google Scholar
• Zhang J, Lou W. A key mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network linked to diagnosis and prognosis of hepatocellular carcinoma. Front Oncol. 2020;10:340.
   PubMed Web of Science ®Google Scholar
• Krabbe LM, Margulis V, Lotan Y, et al. Prognostic role of cell cycle and proliferative markers in clear cell renal cell carcinoma. Urol Clin North Am. 2016;43:105–118.
   PubMed Web of Science ®Google Scholar
• Ucakturk E, Akman O, Sun X, et al. Changes in composition and sulfation patterns of glycoaminoglycans in renal cell carcinoma. Glycoconj J. 2016;33(1):103–112.
   PubMed Web of Science ®Google Scholar
• Matsuyama M, Yoshimura R, Mitsuhashi M, et al. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway. Oncol Rep. 2005;14:73–79.
   PubMed Web of Science ®Google Scholar
• Chen C, Sheng Y. Prognostic Impact of MITD1 and associates with immune infiltration in kidney renal clear cell carcinoma. Technol Cancer Res Treat. 2021;20:1-9.
   Google Scholar
• Na JC, Nagaya N, Rha KH, et al. DNA damage response pathway alteration in locally advanced clear-cell renal-cell carcinoma is associated with a poor outcome. Clin Genitourin Cancer. 2019;17(4):299–305.e1.
   PubMed Web of Science ®Google Scholar